Invention Grant
- Patent Title: Polyomavirus neutralizing antibodies
-
Application No.: US16183262Application Date: 2018-11-07
-
Publication No.: US10654914B2Publication Date: 2020-05-19
- Inventor: Johanna Abend , Zorica Dragic , Adam Lloyd Feire , Mark Knapp , Steven Kovacs , Elisabetta Traggiai , Lichun Wang , Yongqiang Wang , Danqing Wu , Qilong Wu , Fangmin Xu
- Applicant: Novartis AG
- Applicant Address: CH Basel
- Assignee: Novartis AG
- Current Assignee: Novartis AG
- Current Assignee Address: CH Basel
- Agency: Cooley LLP
- Priority: com.zzzhc.datahub.patent.etl.us.BibliographicData$PriorityClaim@361e59d1
- Main IPC: A61K9/19
- IPC: A61K9/19 ; A61K39/42 ; C07K16/08 ; A61K45/06
Abstract:
The present invention relates to anti-VP1 antibodies, antibody fragments, and their uses for the prevention and treatment of polyoma virus infection and associated diseases.
Public/Granted literature
- US20190071488A1 POLYOMAVIRUS NEUTRALIZING ANTIBODIES Public/Granted day:2019-03-07
Information query
